Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Vertex Pharmaceutic (VRTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 33,250,846
  • Shares Outstanding, K 249,070
  • Annual Sales, $ 1,702 M
  • Annual Income, $ -112,050 K
  • 36-Month Beta 1.65
  • Price/Sales 19.83
  • Price/Cash Flow 964.75
  • Price/Book 20.06

Price Performance

See More
Period Period Low Period High Performance
1-Month
115.10 +15.99%
on 05/24/17
137.26 -2.74%
on 06/22/17
+16.91 (+14.50%)
since 05/23/17
3-Month
88.90 +50.17%
on 03/27/17
137.26 -2.74%
on 06/22/17
+44.45 (+49.92%)
since 03/23/17
52-Week
71.46 +86.82%
on 12/22/16
137.26 -2.74%
on 06/22/17
+45.30 (+51.36%)
since 06/23/16

Most Recent Stories

More News
OpportunityAnalyzer Report 2017: Cystic Fibrosis - Opportunity Analysis and Forecasts to 2025

Research and Markets has announced the addition of the "OpportunityAnalyzer: Cystic Fibrosis - Opportunity Analysis and Forecasts to 2025" drug pipelines to their offering. Global (7MM) sales for the...

JNJ : 136.43 (+0.28%)
VRTX : 133.50 (-1.50%)
NVS : 86.34 (unch)
RPTP : 9.00 (unch)
Here's Why Investors Are Glued to Vertex Pharma (VRTX) Stock

Vertex Pharmaceuticals, Inc. (VRTX), has been attracting investor attention.

CNCE : 14.53 (-0.68%)
VVUS : 1.22 (+5.17%)
VRTX : 133.50 (-1.50%)
REGN : 517.33 (-1.75%)
BNBuilders Tops Out Vertex Pharmaceuticals New Building

BNBuilders (www.bnbuilders.com) and Alexandria Real Estate Equities, Inc. (www.are.com) are pleased to announce the topping out of Vertex Pharmaceuticals' new San Diego laboratory last month. The milestone...

VRTX : 133.50 (-1.50%)
Fresh Capital to Be Injected into Biotech Stocks: 5 Must-Buys

IBB surged 17% since Trump's win but is still down 23% from its all-time intraday high scaled in the July of 2015.

ESPR : 44.34 (+4.80%)
PBYI : 87.50 (+1.21%)
AVXL : 5.70 (+2.89%)
IBB : 320.74 (+0.20%)
VRTX : 133.50 (-1.50%)
GERN : 2.94 (unch)
REGN : 517.33 (-1.75%)
KITE : 100.66 (+7.10%)
CALA : 15.25 (+1.67%)
HSGX : 1.85 (+3.35%)
CBM : 60.40 (-0.82%)
Biotech Stock Roundup: Clovis Soars on Rubraca Data, Seattle Hit by Study Halt

Key highlights in the biotech sector include positive data on Clovis' (CLVS) PARP inhibitor, Rubraca.

CELG : 134.31 (+0.47%)
VRTX : 133.50 (-1.50%)
CLVS : 95.00 (-1.84%)
GILD : 70.52 (+0.06%)
SGEN : 61.74 (-2.39%)
REGN : 517.33 (-1.75%)
AMGN : 172.50 (-0.76%)
BIIB : 280.32 (-0.09%)
No Energy to Follow Through

No Energy to Follow Through

HIVE : 5.42 (+3.24%)
RWLK : 2.40 (+33.33%)
COP : 44.83 (+0.04%)
IMDZ : 9.65 (+14.20%)
VRTX : 133.50 (-1.50%)
EPZM : 14.70 (+7.69%)
Zacks.com featured highlights: Etsy, Live Nation Entertainment, Salesforce.com, Vertex Pharmaceuticals and NeoGenomics

Zacks.com featured highlights: Etsy, Live Nation Entertainment, Salesforce.com, Vertex Pharmaceuticals and NeoGenomics

ETSY : 15.24 (+3.81%)
LYV : 34.84 (+1.31%)
VRTX : 133.50 (-1.50%)
NEO : 8.87 (+1.95%)
CRM : 88.62 (+0.17%)
Vertex Pharmaceuticals Rises 2.41% on Heavy Volume: Watch For Potential Pullback

Vertex Pharmaceuticals (NASDAQ:VRTX) traded in a range yesterday that spanned from a low of $123.79 to a high of $126.37. Yesterday, the shares gained 2.4%, which took the trading range above the 3-day...

VRTX : 133.50 (-1.50%)
5 Toxic Stocks to Discard or Play Short for Profit

If you can pinpoint the toxic stocks accurately, you may gain by resorting to an investing strategy called short selling.

ETSY : 15.24 (+3.81%)
LYV : 34.84 (+1.31%)
VRTX : 133.50 (-1.50%)
NEO : 8.87 (+1.95%)
CRM : 88.62 (+0.17%)
Vertex Pharmaceuticals Shares Up 58.0% Since SmarTrend's Buy Recommendation (VRTX)

SmarTrend identified an Uptrend for Vertex Pharmaceuticals (NASDAQ:VRTX) on January 6th, 2017 at $78.63. In approximately 5 months, Vertex Pharmaceuticals has returned 58.01% as of today's recent price...

VRTX : 133.50 (-1.50%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More

Business Summary

Vertex Pharmaceuticals Inc. discovers, develops and markets small molecule drugs that address major unmet medical needs. The company has eight drug candidates in clinical development to treat viral diseases, inflammation, cancer, autoimmune diseases and neurological disorders. Vertex has created its...

See More

Support & Resistance

2nd Resistance Point 139.09
1st Resistance Point 136.29
Last Price 133.50
1st Support Level 131.41
2nd Support Level 129.33

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.